Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,390 INR | +3.83% | -4.18% | -2.97% |
May. 29 | Indian Equities Dragged Down by Losses in Financial, IT Stocks | MT |
May. 28 | Bharti AXA Life-SBI Life Sale Talks Reportedly Collapse | CI |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Sales forecast by analysts have been recently revised upwards.
Weaknesses
- Low profitability weakens the company.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 72.19 times its estimated earnings per share for the ongoing year.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.97% | 16.05B | C+ | ||
+6.90% | 103B | B | ||
+12.65% | 102B | B- | ||
-13.08% | 84.11B | B+ | ||
+13.08% | 70.25B | D+ | ||
+21.61% | 35.06B | B | ||
+18.18% | 31.34B | B | ||
+14.20% | 29.6B | A | ||
-14.65% | 13.76B | B | ||
+18.29% | 12.65B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SBILIFE Stock
- Ratings SBI Life Insurance Company Limited